A inmunohistochemistry study of P53 protein in squamous cell carcinoma of the larynx;Proteína P53 mediante inmunohistoquímica en el carcinoma epidermoide de laringe

Acta Otorrinolaringologica Espanola

Volumn 54, Issue 4, 2003, Pages 263-268

  Perez Carro Rios A ^a   Lozano Ramirez A ^b   Garcia Caballero T ^b   Labella Caballero, T ^b   Clemente Garcia A ^a  

^a HOSPITAL XERAL CÍES   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Larynx; P53; Squamous cell carcinoma; Suppress protein; Survival

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LOG RANK TEST; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; WILD TYPE; CULTURE TECHNIQUE; LARYNX TUMOR; METABOLISM; MORTALITY; PATHOLOGY; SURVIVAL RATE;

CARCINOMA, SQUAMOUS CELL; CULTURE TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0042071411     PISSN: 00016519     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-6519(03)78413-1     Document Type: Article

References (29)

1. Lane D, Benchimol S. p53: oncogen or anti-oncogen? Genes & Development 1990; 4: 1-8.
2. Levine A, Momand J, Finlay C. The P53 tumor suppressor gene. Nature 1991; 351: 453-456.
3. Field JK, Spandidos DA, Malliri A , Gosney JR, YIagnisis M. Elevated P53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Cancer 1991; 64: 573-577.
4. Lane DP, Crawford LV. Tantigen is bound to a host protein in SV40 transformed cells. Nature, 1979; 278: 261-263.
5. Levine A. Tumor suppressor genes. BioEssays 1990; 12: 60-66.
6. Field J, Pavelic Z,Spandidos D, Stambrook P, Jones A. The role of P53 tumor supressor gene in squamous cell carcinoma of the head and neack. Arch Otorrinolaryngol Head Neck Sur 1993; 119: 1118-1123 .
7. Abraldes M. Estudio imnunofenotípico y molecular de los melanomas de la úvea. Cum Lauden Thesis, Santiago de Compostela. 218 págs., 1996.
8. Levine A, Perry M, Chang A, Silver A, Dittmer D, Wu M, et al. The 1993 Walter Hubert Lecture: The role of the p53 tumor-suppressor gene in tumorigenesis. Cancer 1994; 69: 409-416.
9. Gándara Porres I, González Barón M. Bases moleculares del cáncer. Aplicaciones diagnósticas. Medicine 1995; 6(79): 3473-3479.
10. Allred C, Clark G, Elledge R. A ssociation of P53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. Journal of the National Cancer Institute 1993; 85: 200-206.
11. Watling D, Gown A, Coltrera M. Overexpression of P53 in head and neck cancer. Head and Neck 1992; 14: 437-444.
12. Lodish H, Baltimore D, Berk A . Molecular cell biology. Third ed. Vol. 1. Scientific American Books, New York. 1344 págs., 1995.
13. Earl Ruley H. p53 and response to chemotherapy and radiotherapy. 1st ed. Lippincott-Raven, Philadelphia. (Important Advances in Oncology), 1996.
14. Brostoff J, Scadding G, Male D, Roitt I. Inmunología clínica. Gower Medical Publishing ed. Vol. 1., London. 1619 págs., 1994.
15. Beesley J. Immunocytochemistry. A Practical Approach. Beesley, J, Oxford. 248 págs., 1993.
16. Pardo Mindán J, Panizo A, Martínez L. Valoración del sistema de polímeros de dextrano En Vision (PDE) en la detección inmunohistoquímica. Revista Española Patología 1998; 31: 9-16.
17. Leong A. Applied immunohistochemistry for the surgical pathologist. 1st ed. Edward Arnold a member of the Hodder Headline Group, London. 210 pages. 1993.
18. Bisgaard K. Polymeric conjugates for enhanced signal generation in enzyme immunoassays. Scand Soc for Immunol. (XXIVth Annual Meeting. Aarthus), 1993.
19. Golusinski W, Szmeja Z, Olofsson J, Biczysko W, Krygier-Stojalzowska A, Majewski P. Retrospective analysis of selected tumour markers (p53, PCNA, Ki67; DNA ploidy) and ultrastructure in patients with larynx carcinomas. HNO 1998; 46: 233-40.
20. Pruneri G, Pignataro L, Carboni N, Ronchetti D, Cesana BM, Ottaviani A, et al. Clinical relevance of p53 and bcl-2 protein over-expression in laryngeal squamous-cell carcinoma. Int J Cancer 1998; 79: 263-8.
21. Hirvikoski P, Kumpulainen E, Vi rtaniemi J, Johansson R, Haapasalo H, Marin S, et al. p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma. J Clin Oncol 1997; 15: 3111-2 0 .
22. Rowley H, Roland NJ, Helliwell TR, Caslin A, Kinsella AR, Jones A S . p53 protein expression in tumours from head and neck subsites, larynx and hypopharynx, and differences in relationship to survival. Clin Otolaryngol 1998; 23: 57-62.
23. Xie M, Xiao J, Tao Z, Luo J. A preliminary study on p53 gene expression and infection of human papilloma virus in laryngeal squamous cell carcinoma. Hunan I Ko Ta Hsueh Hsueh Pao 1997; 22: 209-11 .
24. Pekkola-Heino K, Servomaa K, Kiuru A, Grenman R. Increased radiosensitivity is associated with p53 mutations in cell lines derived from oral cavity carcinoma. Acta Otolaryngol (Stockh) 1996; 116: 341-344.
25. Jin Y T, Kayser S, Kemp BL, Ordonez NG, Tucker SL, Clayman GL, et al. The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinoma. Cancer 1998; 82: 2159-65.
26. del Valle Zapico A, Fernández Fernández F, Mayorga Fernández M, Rubio Suárez A, Morales Angulo C, Rama Quintela J. Overexpression of p53 protein in epidermoid carcinoma of the pyriform sinus. Acta Otorrinolaringol Esp 1998; 49: 133-6.
27. Stoll C, Baretton G, Lohrs U. The influence of p53 and associated factors on the outcome of patients with oral squamous cell carcinoma. Vi rchows Arch 1998; 433: 427-33.
28. Mineta H, Borg A, Dictor M, Wahlberg P, Akervall J, Wennerberg J. p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma. Br J Cancer 1998; 78: 1084-90.
29. Chiang CP, Huang JS, Wang JT, Liu BY, Kuo YS, Hahn LJ, et al. Expression of p53 protein correlates with decreased survival in carcinomas in Taiwan. J Oral Pathol Med 1999; 28: 72-6.